Where is Metabolus located?

Metabolus is headquartered in San Diego, United States.

How many employees does Metabolus have?

As of Dec 31, 2022, the latest employee count at Metabolus is 33.

Is Metabolus a funded company?

Metabolus is a funded company, having raised a total of $***** in its 1st and only funding round.

Where does Metabolus rank among its competitors?

Metabolus ranks 13th amongst 10 active competitors, of which 4 are funded. It stands 11th in terms of total funding among its competitors.

Who are the top competitors of Metabolus?

Metabolus' top competitors include Linus Biotechnology, Lineagen and MARAbio.

Metabolus - 2025 Company Profile, Team, Funding & Competitors

Company Details

Metabolus develops diagnostics for neurodegenerative and neuropsychiatric disorders. Its assays are based on biomarkers associated with common CNS disorders who do not have reliable genetic markers. First application is a diagnostic assay for autism spectrum disorders that appears to use metabolomics.

Key Metrics

Founded Year

2015

Location

San Diego, United States

Stage

Deadpooled

Investors

ScholarNexus

Ranked

13^th among 16 competitors

Employee Count

33 as on Dec 31, 2022

Similar Companies

Linus Biotechnology & 10 more

View Metabolus' full profile

Metabolus is a funded company. Metabolus has 1 institutional investor.

View details of Metabolus's funding rounds and investors

The founders of Metabolus is William Alaynick.

Here are the details of Metabolus' key team members:

William Alaynick: CEO & Founder of Metabolus and founder of 2 other companies, Defined Bioscience and Arima Genomics.

View details of Metabolus's Founder profiles and Board Members

Metabolus' employee count trend

Metabolus has 33 employees as of Dec 22. The total employee count is 11.0% lower than what it was in Dec 21. Here is Metabolus's employee count trend over the years:

Uncover Metabolus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Metabolus include Linus Biotechnology, Lineagen and MARAbio. Here is the list of Top 10 competitors of Metabolus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Linus Biotechnology 2020, New York City (United States), Series A	Developer of diagnostic tests for central nervous system and gastrointestinal disorders	$47.6M	GreatPoint Ventures, Bow Capital & 3 others	48/100
2nd	Lineagen 2002, Salt Lake City (United States), Acquired	Sequencing-based diagnostic test and consultative services for autism	$66.9M	Sanderling Ventures, Mesa Verde Venture Partners ... & 10 others	39/100
3rd	MARAbio 2016, Salt Lake City (United States), Series A	Developer of blood test for detecting maternal autoantibody-related autism	$19.1M	Moai Capital, MAK Capital	35/100
4th	SynapDx 2010, Southborough (United States), Deadpooled	Developer of blood-based diagnostic tests for the early detection of autism	$32.7M	Casdin Capital, North Bridge Venture Partners ... & 7 others	33/100
5th	SensOmics 2007, Toronto (Canada), Seed	Provider of precision medicine for children's health	-	Asset Management Ventures, iSeed Ventures	21/100
6th	FBB Biomed 2020, Coralville (United States), Seed	Developer of in-vitro diagnostic test for COVID-19 and neurological diseases	$401K	-	21/100
7th	NeuracleGenetics 2018, Seoul (South Korea), Unfunded	Developing gene therapies using adeno associated virus technology to treat various diseases	-	-	19/100
8th	Pediatric Bioscience 2006, Sacramento (United States), Deadpooled	Blood biomarker based diagnostics for Autism Spectrum Disorders	$2.44M	Tech Coast Angels, Arizona Tech Investors	19/100
9th	Autism Diagnostic Technologies 2019, Basking Ridge (United States), Deadpooled	Developer of software for autism diagnosis	-	-	18/100
10th	Analutos 2010, Sunderland (United Kingdom), Unfunded	Mass Spectrometry-based tests for autism spectrum disorders & Dysbiosis	-	-	17/100
13th	Metabolus 2015, San Diego (United States), Deadpooled	Diagnostics for neurodegenerative and neuropsychiatric disorders	-	ScholarNexus	14/100